You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development of DT-110 as an oral therapeutic for type 2 diabetes
SBC: Diapin Therapeutics LLC Topic: 200DESCRIPTION provided by applicant Type diabetes is a chronic debilitating disease that threatens to reach pandemic level by Nearly million people worldwide are currently affected by diabetes and more than of patients with type diabetes die of cardiovascular causes However no particular diabetes medication to date is considered superior in the minimization of the risk of card ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Isolation and Characterization of Low Molecular Weight Compounds Derived from Plant Extracts that Activate the IRS-2 Dependent Insulin Signaling Cascade.
SBC: HOUSEY PHARMACEUTICAL RESEARCH LAB Topic: 200DESCRIPTION provided by applicant This is a Phase I SBIR Application entitled andquot Isolation and Characterization of Low Molecular Weight Compounds Derived from Plant Extracts that Activate the IRS Dependent Insulin Signaling Cascade andquot Diabetes is a growing and significant global health concern Insulin Receptor Substrate IRS is a critical component in the insulin mediated s ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
SBC: HOUSEY PHARMACEUTICAL RESEARCH LAB Topic: 102DESCRIPTION provided by applicant This is a Phase I SBIR Application entitled andquot Novel Inhibitors of Multi Drug Resistant Mutants of BCR ABL for the Treatment of Chronic Myelogenous Leukemia CML and Ph Acute Lymphocytic Leukemia ALL andquot The overall goal of this proposal is to further optimize and improve the efficacy of novel classes of compounds discovered developed and patent ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Improving Outcomes for Mechanically Ventilated Patients with the Digital EZ Board
SBC: VIDATAK, LLC Topic: 600DESCRIPTION provided by applicant Effective communication between patients and healthcare professionals is essential to achieve positive clinical outcomes Patients who are unable to communicate effectively e g patients with limited English proficiency LEP those who are hearing impaired aphasic or have oral tracheal intubation experience extreme frustration panic anxiety sleeplessne ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Personalized Smoking Cessation Tool based on patient lung CT image
SBC: Imbio, LLC Topic: 102DESCRIPTION provided by applicant In this project we proposes to design a patient report based on Imbioandapos s Lung Density Analysis a CT image processing application that will increase a patientandapos s motivation to make a quit attempt by providing compelling visual feedback on the state of their lung health comparative data with peers and individualized predictions of long term health ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Quantitative Superplexing: Single-tube, many-target qPCR for cancer diagnostics
SBC: ASURAGEN, INC. Topic: 102DESCRIPTION provided by applicant A novel andquot Superplexandquot RT qPCR strategy will be optimized for the single tube amplification and quantification of targeted panels of fusion transcripts that can be broadly applicable for the rapid development of clinical cancer diagnostic assays The novel design will enable accurate and reproducible quantitative detection of mid sized RNA panels more ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Custom Fit 3D-Printed Pediatric Respiratory Masks
SBC: ADVANCED MEDICAL ELECTRONICS CORP Topic: NICHDDESCRIPTION provided by applicant This project will develop an FDA approved process D printing system and advanced D printable material suitable for point of care manufacturing of custom fit continuous positive airway pressure CPAP masks for neonates In extremely low birth weight infants nasal CPAP therapy is delivered via soft biocompatible neonatal sized nasal masks suitable for lon ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
NEOSAFE Novel material for manufacturing of neonatal devices via 3D Printing
SBC: LYNNTECH INC. Topic: NICHDDESCRIPTION provided by applicant Complications from preterm birth and during childbirth are among the top three killers of children under five Many newborns require immediate medical attention in the neonatal intensive care units NICU where they are subjected to medical procedures that require specialized medical devices Despite the advances in research and development of novel medical de ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Development of a reliable and standardized molecular assay for fragile x protein
SBC: ASURAGEN, INC. Topic: NICHDDESCRIPTION provided by applicant The goal of this project is to develop a validated quantitative assay for the fragile X mental retardation protein FMRP to aid in the clinical management of those with fragile X syndrome FXS autism and other disorders and to advance FXS research FXS is the leading form of inheritable intellectual disability ranging from mild to severe and is the most co ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Superior laryngeal nerve stimulation for the treatment of neurogenic dysphagia in an animal model of amyotrophic lateral sclerosis
SBC: NURO INC Topic: NIDCDDESCRIPTION provided by applicant Dysphagia refers either to the difficulty with the initial phases of a swallow or to the sensation that foods and or liquids are somehow being obstructed in their passage from the mouth to the stomach As many as Americans are newly diagnosed with dysphagia each year primarily as a result of neurological diseases like amyotrophic lateral sclerosis ALS ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health